Claris Biotech I Final Closing
Claris Ventures announces final closing: €85m ($100m) for Italian Biotech Fund oversubscription, one year after its launch by the Turin based SGR […]
Autore: admin
NeoPhore Announces $21m Financing to Advance DNA Mismatch Repair Pipeline
NeoPhore Announces $21m Financing to Advance DNA Mismatch Repair Pipeline Round led by Claris Ventures with 2Invest, 3B Future Health Fund and […]
CLARIS VENTURES LANCIA UN FONDO DEDICATO AL BIOTECH ITALIANO
Primo closing a quota €30m per Claris Biotech I, fondo biotech promosso da Claris Ventures SGR Torino, 1 settembre 2020 – Claris […]
Claris Ventures sulla rivista Prisma di Aprile
La rivista Prisma dedica un articolo a Claris Ventures La rivista Prisma nel mese di aprile dedica un articolo a Claris Ventures. […]
COVID-19: Claris Ventures publishes its report on vaccines and drugs in development
Covid-19: new report from Claris Ventures on development of drugs and vaccines Claris Ventures pubblished a Vaccines & Treatments Development Snapshot for […]
Business Insider: Claris, il primo fondo di venture capital italiano che investe solo nel biotech tricolore
Business Insider: Claris, il primo fondo di venture capital italiano che investe solo nel biotech tricolore Ciro Spedaliere, Managing Partner of Claris […]
VentureUp Forum 2020
Ciro Spedaliere from Claris Ventures in the Life Science Panel of Aifi VentureUp Forum 2020 Ciro Spedaliere, Partner of Claris Ventures, will […]
Claris Ventures special guest at 39° Congresso Nazionale della Società Italiana di Farmacologia (SIF)
Claris Ventures special guest at 39° Congresso Nazionale della Società Italiana di Farmacologia (SIF) The 39° National Congress of the Italian Pharmacology […]
Kither Biotech raises a €5.6m financing round to support the clinical development of a new drug for cystic fibrosis and other pulmonary diseases
Kither Biotech raises a €5.6m financing round to support the clinical development of a new drug for cystic fibrosis and other pulmonary […]